You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Anion Exchange Resin for Chirality-based Separation of Single-wall Carbon Nanotubes
SBC: Sepax Technologies, Inc. Topic: N/ASepax Technologies, Inc. has identified a new type of anoin-exchange resin which separates single-wall carbon nanotubes (SWCNTs) with >80% recovery yield and resolves in a single pass the chiral tubes of (6,5) well from commercial SWCNT starting materials by Chromatography. Improvement and scale up of the targeted resin production will facilitate the separation of chiral nanotubes for the academic ...
SBIR Phase II 2012 Department of CommerceNational Institute of Standards and Technology -
Improved Microcalorimeter Detectors for X-Ray Chemical Shift Mapping
SBC: STAR CRYOELECTRONICS, LLC Topic: N/AX-ray fluorescence spectroscopy is a widely used and extremely sensitive analytical technique for qualitative as well as quantitative chemical analysis. Superconducting Transition Edge Sensor (TES) microcalorimeter detectors have now been developed that achieve an energy resolution of 2 eV (full width at half maximum) for 1.5 keV X-rays, which is sufficient to enable the measurement of the small s ...
SBIR Phase I 2012 Department of CommerceNational Institute of Standards and Technology -
Oral transmucosal drug delivery system for naltrexone
SBC: BIONEX PHARMACEUTICALS LLC Topic: NIAAADESCRIPTION (provided by applicant): The proposed SBIR Phase II project aims at developing a new drug product, the naltrexone orally dissolving film (ODF), for treatment of alcohol dependence. The naltrexone ODF is a small, thin, and flexible film, containing naltrexone hydrochloride and other excipients. It is applied intra-orally and adheres to the oral mucosa to affect a rapid onset of action d ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Arm Motor Rehabilitation, Entertainment and Cognition System for the Elderly
SBC: Bright Cloud International Corp Topic: NIADESCRIPTION (provided by applicant): It is hypothesized that the use robotic rehabilitation tables coupled with virtual reality games with elderly stroke survivors residents in skilled nursin facilities (SNFs) will: 1) improve and maintain upper extremityuni-manual and bimanual function, reach, strength and ADL independence; 2) improve and maintain cognition (memory, focus, problem solving); and ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Protein Therapeutics for Muscular Dystrophy
SBC: TRIM-EDICINE INC Topic: NIAMSDESCRIPTION (provided by applicant): SBIR 1R43AR060019 Phase II application: Protein Therapeutics for Muscular Dystrophy Principal Investigator: Takizawa, Norio Project Summary: This application requests for a Phase II project for our initial SBIR grant addressing the use of a novel protein therapeutic agent, MG53, for the treatment of muscular dystrophy (1R43AR060019). Our Phase I studi ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Off-the-shelf Dental Regeneration Technologies
SBC: INNOVATIVE ELEMENTS, LLC Topic: NIDCRDESCRIPTION (provided by applicant): Dentin forms the bulk of the tooth and is covered by enamel in the crown of the tooth and cementum in the root. When dental caries breaks down enamel and involves the dentin, the patient experiences pain and thermal sensitivity. The acute phase of dental pulp infection is typically associated with excruciating pain, and if not properly managed, can lead to per ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics
SBC: NOVAFLUX TECHNOLOGIES, INC. Topic: NIDDKDESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in dialysis patients due to exposure to endotoxin has become a central issue in nephrology. The European Renal Association urges the routine use of ultrapure dialysate with bacteria and endotoxin levels of lt 0.1 CFU/ml and lt 0.03 EU/ml, respectively. In the US, the maximum allowable limit of ba ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Point-of Care System for Determination of Bilirubin Capacity in Neonates
SBC: AVIV BIOMEDICAL INC Topic: NIBIBDESCRIPTION (provided by applicant): Uncontrolled hyperbilirubinemia (jaundice) in neonates has long been known to lead to neurological dysfunction including irreversible athetoid cerebral palsy with speech, ocular and hearing impairments, and even death.Contemporary management is based upon monitoring the total serum bilirubin (TBS), taking into account other clinical parameters such as birth wei ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Computer Based Screening for Diabetic Retinopathy
SBC: VisionQuest Biomedical Inc Topic: NEIDESCRIPTION (provided by applicant): The objective of this Phase II competitive renewal project is to implement a clinical study to collect data to validate EyeStar(tm), a software system as the basis for comprehensive telescreening for all stages of diabetic retinopathy (DR). According to the CDC, approximately 80 million people in the U.S. have some form of eye disease, including 20 million dia ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Automated Eye Disease Screening System
SBC: VisionQuest Biomedical Inc Topic: NEIDESCRIPTION (provided by applicant): This proposed project is motivated by the fact that comprehensive, broad-scale screening for eye diseases such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy (DR), including advanced stages, is economically prohibitive without the introduction of computer-assisted diagnosis of retinal images. According to the CDC approximately 80 ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health